Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析

◆英語タイトル:Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1597
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Omnicell Inc (OMCL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Omnicell Inc (Omnicell) provides automation and business analytics software solutions. It offers medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medication use products, nursing floor solutions, central pharmacy solutions, operating room solutions, and medical and surgical supply products. It also offers solutions to non-acute care products including blister cards; pharmacy sealers for medication packaging; automated fillers; pharmacy automation systems; pharmacy printing and labeling solutions, and medication management solutions. The company offers its products through own sales force, distributors and resellers in the US, Canada, the UK, Germany and other regions. Omnicell is headquartered in Mountain View, the US.

Omnicell Inc Key Recent Developments

Feb 06,2020 Omnicell reports fiscal year and fourth quarter 2019 results
Jan 26,2020 Omnicell showcases latest advancements to medication management portfolio at Arab Health Exhibition and Congress
Dec 10,2019 Omnicell to Present Strategic Priorities and Long-Term Financial Targets at Annual Innovation Day for Investors and Analysts
Dec 09,2019 Omnicell and Huron to provide outcome-based professional services

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Omnicell Inc – Key Facts
Omnicell Inc – Key Employees
Omnicell Inc – Key Employee Biographies
Omnicell Inc – Major Products and Services
Omnicell Inc – History
Omnicell Inc – Company Statement
Omnicell Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Omnicell Inc – Business Description
Product Category: Products
Performance
Product Category: Services
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Omnicell Inc – Corporate Strategy
Omnicell Inc – SWOT Analysis
SWOT Analysis – Overview
Omnicell Inc – Strengths
Omnicell Inc – Weaknesses
Omnicell Inc – Opportunities
Omnicell Inc – Threats
Omnicell Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Omnicell Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Omnicell Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Omnicell Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 06, 2020: Omnicell reports fiscal year and fourth quarter 2019 results
Jan 26, 2020: Omnicell showcases latest advancements to medication management portfolio at Arab Health Exhibition and Congress
Dec 10, 2019: Omnicell to Present Strategic Priorities and Long-Term Financial Targets at Annual Innovation Day for Investors and Analysts
Dec 09, 2019: Omnicell and Huron to provide outcome-based professional services
Dec 09, 2019: Omnicell and Kit Check partner to offer cloud-based solution for tracking of controlled substances
Oct 24, 2019: Omnicell achieves record revenue in the third quarter 2019
Oct 17, 2019: Mercy selects Omnicell to automate and digitize medication management
Aug 22, 2019: Omnicell launches Autonomous Pharmacy Vision for retail pharmacies at NACDS
Jul 25, 2019: Omnicell reports results for second quarter 2019
Jul 19, 2019: Omnicell enters partnership with Atrium Health to provide technology and intelligence to help improve medication management
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Omnicell Inc, Key Facts
Omnicell Inc, Key Employees
Omnicell Inc, Key Employee Biographies
Omnicell Inc, Major Products and Services
Omnicell Inc, History
Omnicell Inc, Other Locations
Omnicell Inc, Subsidiaries
Omnicell Inc, Key Competitors
Omnicell Inc, Ratios based on current share price
Omnicell Inc, Annual Ratios
Omnicell Inc, Annual Ratios (Cont...1)
Omnicell Inc, Annual Ratios (Cont...2)
Omnicell Inc, Interim Ratios
Omnicell Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Omnicell Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Omnicell Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Omnicell Inc, Performance Chart (2015 - 2019)
Omnicell Inc, Ratio Charts
Omnicell Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Omnicell Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • The US Oncology Network:企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ecrins Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company offers products such as native and labeled tubulin, tubulin polymerization kit, monoclonal a …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • IVERIC bio Inc (ISEE):企業の財務・戦略的SWOT分析
    Summary IVERIC bio Inc (IVERIC bio) formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt di …
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • Michael Foods, Inc.:企業の戦略・SWOT・財務情報
    Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vectren Corp (VVC):石油・ガス:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • New Age Metals Inc:企業の戦略・SWOT・財務分析
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Awilco LNG ASA (ALNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Awilco LNG ASA (Awilco LNG), a subsidiary of Awilhelmsen AS, is an oil and gas company that provides LNG transportation programs. The company owns and operates LNG vessels intended for international trading. It offers LNG value chain such as liquefaction, production, regasification, transpor …
  • Dignity plc (DTY):企業の財務・戦略的SWOT分析
    Dignity plc (DTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Whole Foods Market Inc:企業のM&A・事業提携・投資動向
    Whole Foods Market Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whole Foods Market Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • PCL Constructors Inc:企業の戦略的SWOT分析
    PCL Constructors Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telecom Egypt Company
    Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report Summary Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Phoenix Beverages Limited:戦略・SWOT・企業財務分析
    Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report Summary Phoenix Beverages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglyc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆